Vanedge Capital Limited Partnership — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
NeuroBionicsneurobionics.ioinNov 2025
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)Nicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)
Co-investorsFuture VenturesGreyMatterVanedge CapitalDolby Family Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.